Gene therapy for hemoglobinopathies
Authors:
- Nora M. GibsonNGNora M. Gibson
- Jaladhikumar PatelJPJaladhikumar Patel
- Janet L. KwiatkowskiJKJanet L. Kwiatkowski
- 1 October 2026
- journal article
- Published by Elsevier in Seminars in Hematology
Abstract
No abstract availableThis publication has 102 references indexed in Scilit:
- Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion‐Dependent β‐ThalassemiaAmerican Journal of Hematology, 2026
- G‐ CSF for Mobilizing CD34 + Cells in Individuals With SCD : A Word of CautionAmerican Journal of Hematology, 2026
- A Combination of Plerixafor and Filgrasting Promotes Successful CD34 + Cell Collection for CRISPR /Cas9 Therapy in Sickle Cell Disease Patients With Insufficient Response to Plerixafor AloneAmerican Journal of Hematology, 2025
- Normalization of Cerebral Hemodynamics After Gene Therapy in Adults With Sickle Cell DiseaseAmerican Journal of Hematology, 2025
- Effect of allogeneic hematopoietic stem cell transplantation on sickle cell disease‐related organ complications: A systematic review and meta‐analysisAmerican Journal of Hematology, 2024
- Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 studyAmerican Journal of Hematology, 2022
- Trends in Sickle Cell Disease–Related Mortality in the United States, 1979 to 2017Annals of Emergency Medicine, 2020
- Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi‐center HGB‐206 trialAmerican Journal of Hematology, 2020
- Improved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell DiseasePediatric Blood & Cancer, 2016
- Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathiesAmerican Journal of Hematology, 2015